WTT yields 47.10% · PFE yields 6.13%● Live data
📍 WTT pulled ahead of the other in Year 1
Combined, WTT + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WTT + PFE for your $10,000?
Wireless Telecom Group, Inc., together with its subsidiaries, designs, develops, manufactures, and markets radio frequency (RF) and microwave devices in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company also engages in development, testing, and deployment of wireless technology. In addition, it offers power meters and sensors, voltmeters, and audio and modulation analyzers for radar, avionics, electronic warfare, electromagnetic interference compatibility, and satellite and wireless communications applications; and noise generation instruments, calibrated noise sources, noise modules, and diodes. Further, the company provides phase noise analyzers and signal generators; embedded signal processing and radio frequency modules; and long-term evolution physical layer and stack software for mobile network and related applications. It serves wireless carriers, aerospace and defense companies, military and government agencies, satellite communication companies, network equipment manufacturers, semiconductor companies, system integrators, tower companies, neutral host providers, medical device manufacturers, and other technology companies. The company markets its products under the Boonton, Noisecom, Holzworth, and CommAgility brands through its in-house sales force, manufacturers' representatives, and distributors. Wireless Telecom Group, Inc. was incorporated in 1985 and is headquartered in Parsippany, New Jersey.
Full WTT Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.